Writing on his web site, stemcellbattles.com, he quoted a section that said,
“Given the time and expense of therapy development, it is unlikely that CIRM will be able to fully develop stem cell therapy for routine clinical use during the ten years of the plan.”Then he remarked,
"I differ with that assessment with every fiber of my being."Reed's comments can be found towards the end of the Oct. 4 item, which also has some interesting remarks on the recent round of stem cell meetings in California.
No comments:
Post a Comment